T-Cell Dysfunction in Hairy Cell Leukemia: An Updated Review

References

• Cawley J. C., Burns G. F., Hayhoe F. G. J. Hairy cell leukemia. Springer Verlag, Berlin 1980; 85–86
   Google Scholar
• Wu S. H., Vendantham S., Rosner M. C., Lovis R. M., Golomb H. M., Gamliel H. Ultrastructural characteristics of the spleen in hairy cell leukemia. Leukemia and Lymphoma 1992; 8: 137–142
   PubMed Web of Science ®Google Scholar
• Knight R. A., Worman C. P., Cawley J. C. Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia. Clinical Experimental Immunology 1983; 53: 600–604
   PubMed Web of Science ®Google Scholar
• Ruco L. P., Procopio A., Maccalini V., Calogero A., Uccini S., Annino L., Mandelli F., Baroni C. D. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 1983; 61: 1132–1137
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Agostini C., Ambrosetti A., Chisesi T., Raimondi R., Bulian P., Pizzolo G., Semenzato G. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia. Blood 1990; 75: 1525–1530
   PubMed Web of Science ®Google Scholar
• Demeter J., Benczur M. Hairy cells are not lysed by autologous LAK cells. Blut 1989; 58: 49–50
   PubMedGoogle Scholar
• Quesada J. R., Hersh E. M., Manning J., Reuben J., Keating M., Schnipper E., Itri L., Gutterman J. U. Treatment of hairy cell leukemia with recombinant α-interferon. Blood 1986; 68: 493–497
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Jacobs A., Fefer A., Ozer H., Thompson J., Portlock C., Rarain M., Golde D., Vardiman J., Burke J. S., Brady J., Bonnem E., Spiegel R. Alpha-2-interferon therapy of hairy cell leukemia: a multicenter study of 64 patients. Journal of Clinical Oncology 1986; 4: 900–905
   PubMed Web of Science ®Google Scholar
• Lauria F., Foa R., Raspadori D., Zinzani P. L., Buzzi M., Fierro M. T., Bonferroni M., Fanin R., Gallizia C., Michieli M. G., Degani G., Resegotti L., Tura S. Treatment of hairy-cell leukaemia with α-interferon (α-IFN). European Journal of Cancer and Clinical Oncology 1988; 24: 195–200
   PubMedGoogle Scholar
• Jaiyesimi I. A., Kantarjian H. M., Estey E. H. Advances in therapy for hairy cell leukemia. Cancer 1993; 72: 5–15
   PubMed Web of Science ®Google Scholar
• Horst Van Der F. A. L., Marel Van Der A., Ottolander Den G. J., Kluin-Nelemans J. C. Decrease of memory T-helper-cells (CD4+CD45RO+) in hairy cell leukemia. Leukemia 1993; 7: 46–50
   PubMed Web of Science ®Google Scholar
• Romagnani S. Lymphokine production by human T-cells in disease status. Annual Review of Immunology 1994; 12: 227–257
   PubMed Web of Science ®Google Scholar
• Janckila A. J., Wallace J. H., Yam L. T. Generalized monocyte deficiency in leukaemic reticuloen-dotheliosis. Scandinavian Journal of Haematology 1982; 29: 153–160
   PubMedGoogle Scholar
• Worman C. P., Cawley J. C. Monoclonal antibody-defined T-cell subsets in hairy cell leukaemia. Scandinavian Journal of Haematology 1982; 29: 338–344
   PubMedGoogle Scholar
• Ford R. J., Mehta S., Sharma S. In vitro studies on leukemic cells and T-lymphocytes in hairy cell leukemia. Leukemia 1987; 1: 386–389
   PubMed Web of Science ®Google Scholar
• Van De Corput L., Kester M. G. D., Falkenburg J. H. F., Willemze R., Kluin-Nelemans J. C. TCRγδ+ cells expressing Vγ9Vδ2, which normally predominate the blood, are found in the spleens of patients with hairy cell leukemia. Leukemia 1997; 11: 106–109
   PubMed Web of Science ®Google Scholar
• GaschÉ C., Reinisch W., Schwarzmeier J. D. Evidence of colony suppressor activity and deficiency of hematopoietic growth factors in hairy cell leukemia. Hematological Oncology 1993; 11: 97–104
   PubMed Web of Science ®Google Scholar
• Briggs P. G., Kraft N., Atkins R. C. T-cells and CD45R expression in B-chronic lymphocytic leukemia. Leukemia Research 1990; 14: 155–159
   PubMed Web of Science ®Google Scholar
• Pinto L., Covas M. J., Victorino R. M. M. Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. Immunology 1991; 73: 147–150
   PubMed Web of Science ®Google Scholar
• Reddy M. M., Grieco M. H. Quantitative changes in T helper inducer (CD4+CD45RbA+), T suppressor inducer (CD4+CD45RA+), T suppressor (CD8+CD11b+), and T cytotoxic (CD8+CD11b-) subsets in human immunodeficiency virus infection. Journal of Clinical and Laboratory Analysis 1991; 5: 96–100
   PubMed Web of Science ®Google Scholar
• Miedema F., Meyaard L., Koot M., Klein M. R., Roos M. T. L., Groenink M., Fouchier R. A. M., Van'T Wout A. B., Tersmette M., Schellekens P. T. A., Schuitemaker H. Changing virus-host interactions in the course of HIV-1 infection. Immunological Reviews 1994; 140: 35–72
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans J. C., Kester M. G. D., Oving I., Cluitmans F. H. M., Willemze R., Falkenburg J. H. F. Abnormally activated T-lymphocytes in the spleen of patients with hairy cell leukemia. Leukemia 1994; 8: 2095–2101
   PubMed Web of Science ®Google Scholar
• Schwartzentruber D. J., Stetler-Stevenson M., Rosenberg S. A., Topalian S. L. Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-a in response to autologous tumor stimulation. Blood 1993; 82: 1204–1211
   PubMed Web of Science ®Google Scholar
• Lindemann A., Ludwig W. D., Oster W., Mertelsmann R., Hermann F. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 1989; 73: 880–884
   PubMed Web of Science ®Google Scholar
• Cordingly F. T., Hoffbrand A. V., Heslop H. E., Turner M., Bianchi A., Reittie J. E., Vyakarnam A., Meager A., Brenner M. K. Tumor necrosis factor as an autocrine tumor growth factor for chronic B-cell malignancies. Lancet 1988; 1: 969–971
   PubMed Web of Science ®Google Scholar
• Buck C., Digel W., Schoniger W., Stefanic M., Raghavachar A., Porzsolt F. Tumor necrosis factor and hairy cell leukemia. Lancet 1988; 2: 402–406
   PubMed Web of Science ®Google Scholar
• Van De Corput L., Kester M. G. D., Falkenburg J. H. F., Willemze R., Kluin-Nelemans J. C. Defective alloresponse of CD4+CD28-T-cells in hairy cell leukemia (HCL). Keystone, Cellular Immunology and the Immunotherapy of Cancer-III, Copper Mountain. Abstract 1997
   Google Scholar
• Azuma M., Cayabyab M., Buck D., Philips J. H., Lanier L. L. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T-lymphocytes. Journal of Experimental Medicine 1992; 175: 353–360
   PubMed Web of Science ®Google Scholar
• Linsley P. S., Brady W., Grosmaire L., Aruffo A., Damle N. K., Ledbetter J. A. Binding of the B-cell activation antigen B7 to CD28 costimulates T-cell proliferation and interleukin 2 mRNA accumulation. Journal of Experimental Medicine 1991; 173: 721–730
   PubMed Web of Science ®Google Scholar
• Rossi E., Matutes E., Morilla R., Owusu-Ankomah K., Heffernan A. M., Catovsky D. Zeta chain and CD28 are poorly expressed on T-lymphocytes from chronic lymphocytic leukemia. Leukemia 1996; 10: 494–497
   PubMed Web of Science ®Google Scholar
• Holland G., Zlotnik A. Interleukin-10 and cancer. Cancer Investigations 1993; 11: 751–758
   PubMed Web of Science ®Google Scholar
• Blay J-Y., Burdin N., Rousset F., Lenoir G., Biron P., Philip T., Banchereau J., Favrot M. C. Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 1993; 82: 2169–2174
   PubMed Web of Science ®Google Scholar
• Cortes J. E., Talpaz M., Cabanillas F., Seymour J. F., Kurzrock R. Serum levels of interleukin-10 in patients with diffuse large cell lymphomas: Lack of correlation with prognosis. Blood 1995; 85: 2516–2520
   PubMed Web of Science ®Google Scholar
• Waal M alefyt, De R., Yssel H., De Vries J. E. Direct effects of IL-10 on subsets of human CD4+ T-cell clones and resting T-cells. Journal of Immunology 1993; 150: 4754–4765
   PubMed Web of Science ®Google Scholar
• Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 1991; 146: 3444–3451
   PubMed Web of Science ®Google Scholar
• Schlaak J. F., Hermann E., Gallati H., Meyer Zum Buschfelde K. H., Fleischer B. Differential effects of EL-10 on proliferation and cytokine production of human γ/δ and α/β T-cells. Scandinavian Journal of Immunology 1994; 39: 209–215
   PubMed Web of Science ®Google Scholar
• Jansen J. H., Wientjes G. J. H. M., Willemze R., Kluin-Nelemans J. C. Production of tumor necrosis factor-α by normal and malignant B-lymphocytes in response to interferon-α, interferon-γ and interleukin-4. Leukemia 1992; 6: 116–119
   PubMed Web of Science ®Google Scholar
• Steis R. G., Marcon L., Clark J., Urba W., Longo D. L., Nelson D. L., Maluish A. E. Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia. Blood 1988; 71: 1304–1309
   PubMed Web of Science ®Google Scholar
• Semenzato G., Foa R., Agostini C., Zambello R., Trentin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G. High serum levels of soluble interleukin-2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987; 70: 396–400
   PubMed Web of Science ®Google Scholar
• Digel W., Porzsolt F., Schmid M., Hermann F., Lesslauer W., Brockhaus M. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and B-type chronic lymphocytic leukemia. Journal of Clinical Investigations 1992; 89: 1690–1693
   PubMed Web of Science ®Google Scholar
• Schmid M., Porzsolt F. Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia. Leukemia and Lymphoma 1995; 17: 401–410
   PubMed Web of Science ®Google Scholar
• Semenzato G., Trentin L., Zambello R., Agostini C., Bulian P., Siviero F., Ambrosetti A., Vinante F., Prior M., Chilosi M., Pizzolo G. Origin of the soluble IL-2 receptor in the serum of patients with hairy cell leukemia. Leukemia 1988; 2: 788–792
   PubMed Web of Science ®Google Scholar
• Richards J. M., Mick R., Latta J. M., Daly K., Ratain M. J., Vardiman J. W., Golomb H. M. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood 1990; 76: 1941–1945
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Ambrosetti A., Vinante F., Chilosi M., Semenzato G. Serum interleukin-2 receptor as index of tumor burden in hairy cell leukemia. Blood 1991; 77: 2540–2541
   PubMed Web of Science ®Google Scholar
• Lauria F., Rondelli D., Raspadori D., Zinzani P. L., Benfenati D., Pileri S., Sabattini E., Tura S. Serum soluble interleukin-2 receptor levels in hairy cell leukemia: Correlation with clinical and hematological parameters and with α-interferon treatment. Leukemia and Lymphoma 1992; 7: 103–107
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans J. C. Hairy cell leukemia and its T-cell interactions. Leukemia and Lymphoma 1991; 4: 159–166
   PubMed Web of Science ®Google Scholar
• Chilosi M., Semenzato G., Cetto G., Ambrosetti A., Fiore-Donati L., Perona G., Berton G., Lestani M., Scarpa A., Agostini C., Trentin L., Zambello R., Masciarelli M., Dazzi F., Finante F., Caligaris-Cappio F., Pizzolo G. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: Relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987; 70: 1530–1535
   PubMed Web of Science ®Google Scholar
• Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M., Johnson L., Alderson M. R., Watson J. D., Gin J. G. Cloning of a T-cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 264: 965–968
   PubMed Web of Science ®Google Scholar
• Giri J. G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L. S., Cosman D., Anderson D. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO Journal 1994; 13: 2822–2830
   PubMed Web of Science ®Google Scholar
• Raulet D. H. The structure, function, and molecular genetics of the gamma/delta T-cell receptor. Annual Review of Immunology 1989; 7: 175–207
   PubMed Web of Science ®Google Scholar
• Moss P. A. H., Rosenberg W. M. C., Bell J. I. The human T-cell receptor in health and disease. Annual Review of Immunology 1992; 10: 71–96
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans J. C., Kester M. G. D., Melenhorst J. J., Landegent J. E., Van De Corput L., Willemze R., Falkenburg J. H. F. Persistent clonal excess and skewed T-cell repertoire in T-cells from patients with hairy cell leukemia. Blood 1996; 87: 3795–3802
   PubMed Web of Science ®Google Scholar
• Wen T., Mellstedt H., Jondal M. Presence of clonal T-cell populations in chronic B-lymphocytic leukemia and smoldering myeloma. Journal of Experimental Medicine 1990; 171: 659–666
   PubMed Web of Science ®Google Scholar
• Farace F., Orlanducci F., Dietrich P-Y., Gaudin C., Angevin E., Courtier M-H., Bayle C., Hercend T., Triebel F. T-cell repertoire in patients with B chronic lymphocytic leukemia. Journal of Immunology 1994; 153: 4281–4290
   PubMed Web of Science ®Google Scholar
• Serrano D., Monteiro J., Allen S. L., Kolitz J., Schulman P., Lichtman S. M., Buchbinder A., Vinciguerra V. P., Chiorazzi N., Gregersen P. K. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T-cell subsets in chronic lymphocytic leukemia. Journal of Immunology 1997; 158: 1482–1489
   PubMed Web of Science ®Google Scholar
• McCormack J. E., Callahan J. E., Kappler J., Marrack P. C. Profound deletion of mature T-cells in vivo by chronic exposure to exogenous superantigen. Journal of Immunology 1993; 150: 3785–3792
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans J. C., Kester M. G. D., Van De Corput L., Boor P. P. C., Landegent J. E., Van Dongen J. J. M., Willemze R., Falkenburg J. H. F. Restoration of abnormal T-cell receptor repertoire during interferon-alfa therapy in patients with hairy cell leukemia. Blood 1996; 88(suppl. 1)241a
   Google Scholar
• Parra E., Wingren A. G., Hedlund G., BjÖRklund M., SjÖGren H.-O., Kalland T., Sansom D., Dohlsten M. Costimulation of human CD4+ T-lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. Journal of Immunology 1994; 153: 2479–2487
   PubMed Web of Science ®Google Scholar
• Lanier L. L., O'Fallon S., Somoza C., Philips J. H., Linsley P. S., Okumura K., Ito D., Azuma M. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T-cell proliferation, cytokine production, and generation of CTL. Journal of Immunology 1995; 154: 97–105
   PubMed Web of Science ®Google Scholar
• Schwartz R. H. T-cell anergy. Scientific American 1993; 269: 48–54
   Google Scholar
• Dubey C., Croft M., Swain S. L. Naive and effector CD4 T-cells differ in their requirements for T-cell receptor versus costimulatory signals. Journal of Immunology 1996; 157: 3280–3289
   PubMed Web of Science ®Google Scholar
• Mondino A., Jenkins M. K. Surface proteins involved in T-cell costimulation. Journal of Leukocyte Biology 1994; 55: 805–815
   PubMed Web of Science ®Google Scholar
• Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J., Nadler L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994; 84: 3261–3282
   PubMed Web of Science ®Google Scholar
• Staunton D. E., Dustin M. L., Springer T. A. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61–64
   PubMed Web of Science ®Google Scholar
• De Fougerolles A. R., Stacker S. A., Schwarting R., Springer T. A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. Journal of Experimental Medicine 1991; 174: 253–267
   PubMed Web of Science ®Google Scholar
• De Fougerolles A. R., Springer T. A. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. Journal of Experimental Medicine 1992; 175: 185–190
   PubMed Web of Science ®Google Scholar
• Mackay C. R., Imhof B. A. Cell adhesion in the immune system. Immunology Today 1993; 14: 99–102
   PubMedGoogle Scholar
• Damle N. K., Klussman K., Linsley P. S., Aruffo A. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T-lymphocytes. Journal of Immunology 1992; 148: 1985–1992
   PubMed Web of Science ®Google Scholar
• Van Seventer G., Shimizu Y., Morgan K., Ginther Luce G., Webb D., Shaw S. Remote T-cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: Demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. European Journal of Immunology 1991; 21: 1711–1718
   PubMed Web of Science ®Google Scholar
• Inghirami G., Wieczorek R., Zhu B-Y., Silber R., Dalla-Favera R., Knowles D. M. Differential expression of LFA-1 molecules in non-Hodgkin's lymphoma and lymphoid leukemia. Blood 1988; 72: 1431–1434
   PubMed Web of Science ®Google Scholar
• Jansen J. H., Harst Van Der D., Wientjes G. H. M., Kooy-Winkelaar Y. M. C., Brand A., Willemze R., Kluin-Nelemans H. C. Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. Blood 1992; 80: 478–483
   PubMed Web of Science ®Google Scholar
• Planken E. V., Dijkstra N. H., Bakkus M., Willemze R., Kluin-Nelemans J. C. Proliferation of precursor B-lineage acute lymphoblastic leukaemia by activating the CD40 antigen. British Journal of Haematology 1996; 95: 319–326
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Kipps T. J. Activated T-cells induce expression of B7/BB1 on normal or leukemic B-cells through a CD40-dependent signal. Journal of Experimental Medicine 1993; 177: 925–935
   PubMed Web of Science ®Google Scholar
• Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T-cells express a ligand for the human B-cell-associated antigen CD40 which participates in T-cell-dependent activation of B-lymphocytes. European Journal of Immunology 1992; 22: 2573–2578
   PubMed Web of Science ®Google Scholar
• Yellin M. J., Sinning J., Covey L. R., Sherman W., Lee J. J., Glickman-Nir E., Sippel K. C., Rogers J., Cleary A. M., Parker M., Chess L., Lederman S. T lymphocyte T-cell-B-cell-activating molecule/CD40-L molecules induce normal B-cells or chronic lymphocytic leukemia B-cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. Journal of Immunology 1994; 53: 666–674
   Google Scholar
• Shamash J., Davies D. C., Rohatiner A. Z. S., Young B. D., Lister T. A. Induction of CD80 expression in low-grade B-cell lymphoma: a potential immunotherapeutic target. Leukemia 1995; 9: 1349–1352
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans J. C., Beverstock G. C., Mollevanger P., Wessels H. W., Hoogendoorn E., Willemze R., Falkenburg J. H. F. Proliferation and cytogenic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84: 3134–3141
   PubMed Web of Science ®Google Scholar